The Europe Artificial Intelligence In Precision Medicine Market should witness market growth of 32.4% CAGR during the forecast period (2022-2028).
The digital revolution has significantly transformed the healthcare industry. Care delivery and system performance are the areas that have best shown how innovation and integration have aided change. As a result of the ability to effortlessly incorporate new technologies like AI, IoT, and ML due to digital convergence, the next wave of revolution in healthcare is already creating the foundation for a customer-driven business model.
One of the most exciting and potentially game-changing opportunities for the life sciences sector is AI. In the upcoming years, it will be a top investment target as other businesses want to take advantage of its potential. Investors are anticipated to enter the AI market early, and the number of applications is anticipated to rise further.
The fastest-growing neurological condition is Parkinson's disease. The progression of the disease has not yet been stopped or reversed by any medicine. The development of PD drugs and the management of the condition are significantly hampered by the lack of accurate diagnostic biomarkers. Clinical signs, mostly involving motor functions, including rigidity and tremor, are commonly used to diagnose the condition. However, motor symptoms frequently don't show up until years after the disease first manifests, which delays diagnosis. The regional market for artificial intelligence in precision medicine is being driven by these factors.
The Germany market dominated the Europe Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $447 Million by 2028.The UK market is anticipated to grow at CAGR of 31.2% during (2022-2028). Additionally, The France market would exhibit a CAGR of 33.3% during (2022-2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
The digital revolution has significantly transformed the healthcare industry. Care delivery and system performance are the areas that have best shown how innovation and integration have aided change. As a result of the ability to effortlessly incorporate new technologies like AI, IoT, and ML due to digital convergence, the next wave of revolution in healthcare is already creating the foundation for a customer-driven business model.
One of the most exciting and potentially game-changing opportunities for the life sciences sector is AI. In the upcoming years, it will be a top investment target as other businesses want to take advantage of its potential. Investors are anticipated to enter the AI market early, and the number of applications is anticipated to rise further.
The fastest-growing neurological condition is Parkinson's disease. The progression of the disease has not yet been stopped or reversed by any medicine. The development of PD drugs and the management of the condition are significantly hampered by the lack of accurate diagnostic biomarkers. Clinical signs, mostly involving motor functions, including rigidity and tremor, are commonly used to diagnose the condition. However, motor symptoms frequently don't show up until years after the disease first manifests, which delays diagnosis. The regional market for artificial intelligence in precision medicine is being driven by these factors.
The Germany market dominated the Europe Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $447 Million by 2028.The UK market is anticipated to grow at CAGR of 31.2% during (2022-2028). Additionally, The France market would exhibit a CAGR of 33.3% during (2022-2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
Scope of the Study
By Application
- Oncology
- Cardiology
- Neurology
- Respiratory
- Others
By Component
- Software
- Hardware
- Service
By Technology
- Deep Learning
- Natural Language Processing
- Querying Method
- Context Aware Processing
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Sanofi S.A.
- NVIDIA Corporation
- Intel Corporation
- Microsoft Corporation
- IBM Corporation
- Google LLC (Alphabet Inc.)
- AstraZeneca PLC
- Tempus, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Artificial Intelligence in precision Medicine Market, by Application
1.4.2 Europe Artificial Intelligence in precision Medicine Market, by Component
1.4.3 Europe Artificial Intelligence in precision Medicine Market, by Technology
1.4.4 Europe Artificial Intelligence in precision Medicine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.3 Market Share Analysis, 2021
3.4 Top Winning Strategies
3.4.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.4.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jan - 2022, Nov) Leading Players
Chapter 4. Europe Artificial Intelligence in Precision Medicine Market by Application
4.1 Europe Oncology Market by Country
4.2 Europe Cardiology Market by Country
4.3 Europe Neurology Market by Country
4.4 Europe Respiratory Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Artificial Intelligence in Precision Medicine Market by Component
5.1 Europe Software Market by Country
5.2 Europe Hardware Market by Country
5.3 Europe Service Market by Country
Chapter 6. Europe Artificial Intelligence in Precision Medicine Market by Technology
6.1 Europe Deep Learning Market by Country
6.2 Europe Natural Language Processing Market by Country
6.3 Europe Querying Method Market by Country
6.4 Europe Context Aware Processing Market by Country
Chapter 7. Europe Artificial Intelligence in Precision Medicine Market by Country
7.1 Germany Artificial Intelligence in Precision Medicine Market
7.1.1 Germany Artificial Intelligence in Precision Medicine Market by Application
7.1.2 Germany Artificial Intelligence in Precision Medicine Market by Component
7.1.3 Germany Artificial Intelligence in Precision Medicine Market by Technology
7.2 UK Artificial Intelligence in Precision Medicine Market
7.2.1 UK Artificial Intelligence in Precision Medicine Market by Application
7.2.2 UK Artificial Intelligence in Precision Medicine Market by Component
7.2.3 UK Artificial Intelligence in Precision Medicine Market by Technology
7.3 France Artificial Intelligence in Precision Medicine Market
7.3.1 France Artificial Intelligence in Precision Medicine Market by Application
7.3.2 France Artificial Intelligence in Precision Medicine Market by Component
7.3.3 France Artificial Intelligence in Precision Medicine Market by Technology
7.4 Russia Artificial Intelligence in Precision Medicine Market
7.4.1 Russia Artificial Intelligence in Precision Medicine Market by Application
7.4.2 Russia Artificial Intelligence in Precision Medicine Market by Component
7.4.3 Russia Artificial Intelligence in Precision Medicine Market by Technology
7.5 Spain Artificial Intelligence in Precision Medicine Market
7.5.1 Spain Artificial Intelligence in Precision Medicine Market by Application
7.5.2 Spain Artificial Intelligence in Precision Medicine Market by Component
7.5.3 Spain Artificial Intelligence in Precision Medicine Market by Technology
7.6 Italy Artificial Intelligence in Precision Medicine Market
7.6.1 Italy Artificial Intelligence in Precision Medicine Market by Application
7.6.2 Italy Artificial Intelligence in Precision Medicine Market by Component
7.6.3 Italy Artificial Intelligence in Precision Medicine Market by Technology
7.7 Rest of Europe Artificial Intelligence in Precision Medicine Market
7.7.1 Rest of Europe Artificial Intelligence in Precision Medicine Market by Application
7.7.2 Rest of Europe Artificial Intelligence in Precision Medicine Market by Component
7.7.3 Rest of Europe Artificial Intelligence in Precision Medicine Market by Technology
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Google LLC (Alphabet Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Intel Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Microsoft Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 IBM Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 NVIDIA Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Tempus, Inc.
8.9.1 Company Overview
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Sanofi S.A.
- NVIDIA Corporation
- Intel Corporation
- Microsoft Corporation
- IBM Corporation
- Google LLC (Alphabet Inc.)
- AstraZeneca PLC
- Tempus, Inc.
Methodology
LOADING...
